Henryk Szymański

St. Hedwig-Krankenhaus — Germany

Medicine · Health Sciences

18h-index1.0kcitations36works0.72yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Respiratory viral infections research(12), Influenza Virus Research Studies(10), Viral gastroenteritis research and epidemiology(10), Probiotics and Fermented Foods(9), Pneumonia and Respiratory Infections(5)

Publications35 total

Immunogenicity and Safety of a Quadrivalent Meningococcal Conjugate Vaccine (MenACYW-TT) Administered with Routine Pediatric Vaccines: A European Randomized Controlled Trial
Infectious Diseases and Therapy·2025· 1 citedOpen Access
A randomised trial of pleuran in paediatric acute gastroenteritis
Scientific Reports·2025Open Access
Practice in bronchiolitis management in Polish hospitals—a multicenter retrospective cohort study
European Journal of Pediatrics·2024· 1 citedOpen Access
Nebulised 3% hypertonic saline versus 0.9% saline for treating patients hospitalised with acute bronchiolitis: protocol for a randomised, double-blind, multicentre trial
BMJ Open·2023· 6 citedOpen Access
Safety and Immunogenicity of a ChAd155-Vectored Respiratory Syncytial Virus Vaccine in Infants 6–7 Months of age: A Phase 1/2 Randomized Trial
The Journal of Infectious Diseases·2023· 9 citedOpen Access
A Multi-Centre, Randomised, Double-Blind, Placebo-Controlled Phase III Clinical Trial Evaluating the Impact of BCG Re-Vaccination on the Incidence and Severity of SARS-CoV-2 Infections among Symptomatic Healthcare Professionals during the COVID-19 Pandemic in Poland—Evaluation of Antibody Concentrations
Vaccines·2022· 8 citedOpen Access
A Multi-Center, Randomised, Double-Blind, Placebo-Controlled Phase III Clinical Trial Evaluating the Impact of BCG Re-Vaccination on the Incidence and Severity of SARS-CoV-2 Infections among Symptomatic Healthcare Professionals during the COVID-19 Pandemic in Poland—First Results
Vaccines·2022· 45 citedOpen Access
Immunogenicity and safety of a quadrivalent high-dose inactivated influenza vaccine compared with a standard-dose quadrivalent influenza vaccine in healthy people aged 60 years or older: a randomized Phase III trial
Human Vaccines & Immunotherapeutics·2021· 36 citedOpen Access
Efficacy of a Cell-Culture–Derived Quadrivalent Influenza Vaccine in Children
New England Journal of Medicine·2021· 30 citedOpen Access
Immunogénicité et tolérance d’un vaccin grippal quadrivalent à haute dose par rapport à un vaccin grippal quadrivalent à dose standard chez des sujets de 60 ans et plus : un essai randomisé de phase III
Infectious Diseases Now·2021
Nebulised ALX-0171 for respiratory syncytial virus lower respiratory tract infection in hospitalised children: a double-blind, randomised, placebo-controlled, phase 2b trial
The Lancet Respiratory Medicine·2020· 123 citedOpen Access
Post hoc analysis of fecal samples from responders and non-responders to Lactobacillus reuteri DSM 17938 intervention
Acta Biochimica Polonica·2020· 7 citedOpen Access
Quadrivalent Influenza Vaccine Prevents Illness and Reduces Healthcare Utilization Across Diverse Geographic Regions During Five Influenza Seasons
The Pediatric Infectious Disease Journal·2019· 43 citedOpen Access
Clinical Presentation of Influenza in Children 6 to 35 Months of Age
The Pediatric Infectious Disease Journal·2019· 18 cited
Lack of Efficacy of Lactobacillus reuteri DSM 17938 for the Treatment of Acute Gastroenteritis: A Randomized Controlled Trial
The Pediatric Infectious Disease Journal·2019· 41 cited
Assessment of an optimized manufacturing process for inactivated quadrivalent influenza vaccine: a phase III, randomized, double-blind, safety and immunogenicity study in children and adults
BMC Infectious Diseases·2018· 9 citedOpen Access
Prevention of vaccine-matched and mismatched influenza in children aged 6–35 months: a multinational randomised trial across five influenza seasons
The Lancet Child & Adolescent Health·2018· 76 cited
Additional file 1: of Assessment of an optimized manufacturing process for inactivated quadrivalent influenza vaccine: a phase III, randomized, double-blind, safety and immunogenicity study in children and adults
Figshare·2018Open Access
Safety, immunogenicity, and lot-to-lot consistency of a split-virion quadrivalent influenza vaccine in younger and older adults: A phase III randomized, double-blind clinical trial
Human Vaccines & Immunotherapeutics·2017· 21 citedOpen Access
Efficacy of Lactobacillus Reuteri DSM 17938 for the Treatment of Acute Gastroenteritis in Children: Protocol of a Randomized Controlled Trial
JMIR Research Protocols·2017· 4 citedOpen Access
page 1 of 2Next →

Frequent Co-authors

Federico Martinón‐Torres(10), Hania Szajewska(8), Teresa Jackowska(7), Carine Claeys(6), José García-Sicilia(6), Iwona Sadowska-Krawczenko(6), Varsha Jain(6), Bruce L. Innis(6), Jerzy Brzostek(6), Jerzy Pejcz(5), Thanyawee Puthanakit(5), Khalequ Zaman(5), Javier Díez‐Domingo(5), Ener Çağrı Dinleyici(5), Saul N. Faust(5), Alfonso Carmona(5), Mirosław Jawień(4), Magdalena Strus(4), Piotr B. Heczko(4), Ignacio Salamanca de la Cueva(4)